Inactive Instrument

ProtoKinetix, Incorporated Stock Other OTC

Equities

PKTX

US7437221002

Biotechnology & Medical Research

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2022 - Sales 2023 - Capitalization 6.58M 8.95M
Net income 2022 -1M -1.36M Net income 2023 - 0 EV / Sales 2022 -
Net cash position 2022 25.55K 34.77K Net cash position 2023 20.41K 27.78K EV / Sales 2023 -
P/E ratio 2022
-4.29 x
P/E ratio 2023
-1.9 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 59.74%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 60 14-05-31
Director of Finance/CFO 66 17-11-13
General Counsel - -
Members of the board TitleAgeSince
Chief Executive Officer 60 14-05-31
Director/Board Member 71 15-06-30
More insiders
ProtoKinetix, Incorporated is a research and development stage biotechnology company. The Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins. The Company’s anti-aging glycopeptide is for ophthalmology, dermatology, transplant support and biomanufacturing. The commercial applications for AAGPs include various health care solutions. In a clinical setting, AAGP is showing its ability to protect cells from inflammation, repair and replace damaged cells and improve cell survivability over time. The Company has not developed a commercially viable product and has not generated any revenue.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW